Option Care Health, Inc. (OPCH)

Market Cap	5.36B
Revenue (ttm)	4.30B
Net Income (ttm)	267.09M
Shares Out	173.50M
EPS (ttm)	1.48
PE Ratio	20.88
Forward PE	26.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,515,897
Open	30.37
Previous Close	30.27
Day's Range	30.09 - 30.97
52-Week Range	24.23 - 35.74
Beta	1.30
Analysts	Strong Buy
Price Target	38.30 (+23.95%)
Earnings Date	Apr 23, 2024

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rhe...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John C. Rademacher
• Employees: 7,802
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH

Financial Performance

In 2023, OPCH's revenue was $4.30 billion, an increase of 9.06% compared to the previous year's $3.94 billion. Earnings were $267.09 million, an increase of 77.40%.

Analyst Forecast

According to 5 analysts, the average rating for OPCH stock is "Strong Buy." The 12-month stock price forecast is $38.3, which is an increase of 23.95% from the latest price.

Price Target

$38.3

(23.95% upside)

Analyst Consensus: Strong Buy